ArticleInternational ophthalmology2018

Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab.

Vasileios Konidaris et al.PubMed ↗Publisher ↗

No numbers read from the abstract.